Back
CAS
59-14-3
Purity
95%
Broxuridine has been used in trials studying the treatment of Leukemia, Stage I Prostate Cancer, Stage IIB Prostate Cancer, and Stage IIA Prostate Cancer.
Properties
Name
Broxuridine
Smiles
OC[C@H]1O[C@H](C[C@@H]1O)N2C=C(Br)C(=O)NC2=O
Targets
Please log in to see this information
5-Br-2'-Udr | 5-Brom-2'-deoxyuridin | 5-Brom-2'-desoxy-uridin | 5-Bromdeoxyuridin | 5-Bromo-2'-deoxy-uridin | 5-bromo-2'-deoxyuridine | 5-bromo-2’-deoxyuridine | 5-bromo-2′-deoxyuridine | 5-bromodeoxyuridine | BrdU | BrdUrd | bromodeoxyuridine | broxuridine
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$19
2 mg
$19
5 mg
$19
10 mg
$19
15 mg
$19
20 mg
$19
25 mg
$19
30 mg
$19
35 mg
$19
40 mg
$19
45 mg
$19
50 mg
$19
75 mg
$19
100 mg
Get a quoteQuantity
1
Total amount
$ 19
5-Br-2'-Udr | 5-Brom-2'-deoxyuridin | 5-Brom-2'-desoxy-uridin | 5-Bromdeoxyuridin | 5-Bromo-2'-deoxy-uridin | 5-bromo-2'-deoxyuridine | 5-bromo-2’-deoxyuridine | 5-bromo-2′-deoxyuridine | 5-bromodeoxyuridine | BrdU | BrdUrd | bromodeoxyuridine | broxuridine
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.